DOJ throws support to Oscar in Florida Blue legal fight

An Oscar Health lawsuit alleging Florida Blue’s broker policy is anticompetitive shouldn’t be dismissed based on the McCarran-Ferguson Act, according to the Department of Justice.

Advertisement

In a statement of interest obtained by the Daily Business Review, the Justice Department said the McCarran-Ferguson Act, which exempts insurance business from most federal regulation, should not be used as a basis to dismiss the case.

Oscar Health sued Florida Blue in November 2018 over its exclusive broker policy, which Oscar argues excludes insurance brokers who work with Florida Blue from selling policies of other insurers. Oscar claimed that Florida Blue’s policy — coupled with its market dominance — allows the insurer to effectively operate as a monopoly.

More articles on payers:
Judge steps down from UnitedHealth case over ‘immoral’ denial of cancer treatment
House Democrats unveil Medicare expansion plan: 8 things to know
Humana posts $566M profit in Q1

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.